Publications by authors named "Michi M Shinohara"

Are you Michi M Shinohara?   Register this Author

Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection.
J Invest Dermatol 2017 Apr 1;137(4):819-827. Epub 2016 Nov 1.
Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Electronic address:

Kikuchi-Fujimoto Disease Associated With Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Am J Dermatopathol 2016 Jun;38(6):e77-80
*Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA; †Division of Hematology, Department of Medicine, University of Washington, Seattle, WA; ‡Division of Hematopathology, Department of Pathology, University of Washington, Seattle, WA; and §Division of Dermatopathology, Department of Pathology, University of Washington, Seattle, WA.

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
N Engl J Med 2016 Jun 19;374(26):2542-52. Epub 2016 Apr 19.
From the University of Washington Medical Center (P.T.N., S. Bhatia, N.J.M., E.M.S., M.M.S., J.A.T., M.A.C.), Fred Hutchinson Cancer Research Center (P.T.N., S. Bhatia, S.P.F., L.L., J.A.T., M.A.C.), Cancer Immunotherapy Trials Network (S.P.F., L.L., M.A.C.), and Cancer Research and Biostatistics (A.M., L.R.S.) - all in Seattle; Johns Hopkins University School of Medicine and Kimmel Cancer Center, Baltimore (E.J.L., S. Berry, D.M.P., W.H.S., J.C.S., J.M.T., S.L.T.), and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda. (E.S.) - both in Maryland; Winship Cancer Institute of Emory University, Atlanta (R.R.K.); Merck Research Laboratories, Kenilworth, NJ (L.A., E.K.C., S.M.T., J.H.Y.); University of California, San Francisco, San Francisco (A.D.), and Stanford University, Stanford (H.E.K., K.M., S.A.R.) - both in California; Mt. Sinai Medical Center, New York (P.A.F.); Yale University, New Haven, CT (H.M.K.); and Ohio State University, Columbus (T.O.).

WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.
EMBO Mol Med 2012 Dec 6;4(12):1294-307. Epub 2012 Nov 6.
Department of Pharmacology, Howard Hughes Medical Institute, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, WA, USA.

OF